FDA Approved: OXCARBAZEPINE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' supplemental application for oxcarbazepine (generic anticonvulsant) under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Oxcarbazepine (Oxcarbazepine)

Snippet

SUPPL AP for OXCARBAZEPINE (OXCARBAZEPINE)